IBSA Group

IBSA Institut Biochimique SA is a privately owned pharmaceutical company founded in Lugano in 1945.
It started to develop its specific identity in 1985, when the current management took over, redefining its strategy and focusing on developing technologies that improve the quality of existing therapeutic solutions.

Today, it is present on 5 continents and over 80 countries. The Group now counts on 16 subsidiaries in Europe, China and USA, and boasts a product portfolio covering 10 major therapeutic areas.
The company employs more than 1,600 people, distributed among its headquarters, subsidiaries and manufacturing sites.
IBSA is one of the four largest operators worldwide in the area of Reproductive Medicine and one of the world’s leaders in hyaluronic acid-based products.

Therapeutic areas:
Reproductive Medicine
Endocrinology
Pain and Inflammation
Osteoarticular
Aesthetic Medicine
Dermatology
Uro-gynaecology
Cardiometabolic
Respiratory
Consumer Health

Company’s Keywords:

pharmaceutical, pharma industry, r, d, cardiovascular, dermatology, dermoaesthetic, endocrinology, fertility, human reproduction, respiratory, rheumatology, pain, inflammation, urology, drugs